Brain Advance Access originally published online on December 5, 2005
Brain 2006 129(2):451-464; doi:10.1093/brain/awh704
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models
Departments of Medical Biosciences, 1 Clinical Chemistry and 2 Pathology, 3 Pharmacology and Clinical Neuroscience, 4 Biochemistry, Umeå University, Umeå and 5 Department of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden
Correspondence to: Stefan L Marklund, Department of Medical Biosciences, Clinical Chemistry, Umeå University, SE-901 85, Umeå, Sweden E-mail: Stefan.Marklund{at}medbio.umu.se
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease afflicting the voluntary motor system. More than 100 different mutations in the ubiquitously expressed enzyme superoxide dismutase-1 (SOD1) have been associated with the disease. To search for the nature of the cytotoxicity of mutant SOD1s, amounts, enzymic activities and structural properties of the protein as well as the CNS histopathology were examined in multiple transgenic murine models. In order to generate the ALS phenotype within the short lifespan of the mouse, more than 20-fold increased rates of synthesis of mutant SOD1s appear to be required. The organs of transgenic mice expressing human wild-type SOD1 or either of the G93A and D90A mutant proteins showed high steady-state protein levels. The major proportion of these SOD1s in the CNS were inactive due to insufficient Cu charging and all contained subfractions with a reduced C57-C146 intrasubunit disulphide bond. Both G85R and the truncated G127insTGGG mutant showed low steady-state protein levels, lacked enzyme activity and had no C57-C146 disulphide bond. These mutants were also enriched in the CNS relative to other organs, suggesting inefficient recognition and degradation of misfolded disulphide-reduced SOD1 in susceptible tissues. In end-stage disease, despite 35-fold differences in levels of mutant SOD1s, similar amounts of detergent-resistant aggregates accumulated in the spinal cord. Small granular as well as larger more diffuse human SOD1 (hSOD1)-inclusions developed in all strains, the latter more pronounced in those with high hSOD1 levels. Widespread vacuolizations were seen in the strains with high levels of hSOD1 but not those with low, suggesting these alterations to be artefacts related to high hSOD1 levels and not to the ALS-causing cytotoxicity. The findings suggest that the motoneuron degeneration could be due to long-term exposure to misfolded aggregation-prone disulphide-reduced SOD1, which constitutes minute subfractions of the stable mutants and larger proportions of the unstable mutants.
Key Words: amyotrophic lateral sclerosis; superoxide dismutase; disulphide bond; misfolding; aggregates
Abbreviations: ALS = amyotrophic lateral sclerosis; CCS = copper chaperone for superoxide dismutase; G127X = Gly127insTGGG; SOD = superoxide dismutase; ww = wet weight
Received July 5, 2005. Revised September 23, 2005. Accepted October 31, 2005.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Tiwari, A. Liba, S. H. Sohn, S. V. Seetharaman, O. Bilsel, C. R. Matthews, P. J. Hart, J. S. Valentine, and L. J. Hayward Metal Deficiency Increases Aberrant Hydrophobicity of Mutant Superoxide Dismutases That Cause Amyotrophic Lateral Sclerosis J. Biol. Chem., October 2, 2009; 284(40): 27746 - 27758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Seetharaman, M. Prudencio, C. Karch, S. P. Holloway, D. R. Borchelt, and P. J. Hart Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis Experimental Biology and Medicine, October 1, 2009; 234(10): 1140 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Prudencio, P. J. Hart, D. R. Borchelt, and P. M. Andersen Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease Hum. Mol. Genet., September 1, 2009; 18(17): 3217 - 3226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bergemalm, K. Forsberg, P. A. Jonsson, K. S. Graffmo, T. Brannstrom, P. M. Andersen, H. Antti, and S. L. Marklund Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis Mol. Cell. Proteomics, June 1, 2009; 8(6): 1306 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Karch, M. Prudencio, D. D. Winkler, P. J. Hart, and D. R. Borchelt Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS PNAS, May 12, 2009; 106(19): 7774 - 7779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tateno, S. Kato, T. Sakurai, N. Nukina, R. Takahashi, and T. Araki Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3 Hum. Mol. Genet., March 1, 2009; 18(5): 942 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, G. W. Farr, C. J. Zeiss, D. J. Rodriguez-Gil, J. H. Wilson, K. Furtak, D. T. Rutkowski, R. J. Kaufman, C. I. Ruse, J. R. Yates III, et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS PNAS, February 3, 2009; 106(5): 1392 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chattopadhyay, A. Durazo, S. H. Sohn, C. D. Strong, E. B. Gralla, J. P. Whitelegge, and J. S. Valentine From the Cover: Feature Article: Initiation and elongation in fibrillation of ALS-linked superoxide dismutase PNAS, December 2, 2008; 105(48): 18663 - 18668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rousseau, J. Schymkowitz, and M. Oliveberg ALS precursor finally shaken into fibrils PNAS, December 2, 2008; 105(48): 18649 - 18650. [Full Text] [PDF]
|
|
|
|
|
|
Y. Furukawa, K. Kaneko, K. Yamanaka, T. V. O'Halloran, and N. Nukina Complete Loss of Post-translational Modifications Triggers Fibrillar Aggregation of SOD1 in the Familial Form of Amyotrophic Lateral Sclerosis J. Biol. Chem., August 29, 2008; 283(35): 24167 - 24176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Urushitani, S. A. Ezzi, A. Matsuo, I. Tooyama, and J.-P. Julien The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS FASEB J, July 1, 2008; 22(7): 2476 - 2487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Proescher, M. Son, J. L. Elliott, and V. C. Culotta Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS Hum. Mol. Genet., June 15, 2008; 17(12): 1728 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, A. Ghosh, H. Baigude, C.-s. Yang, L. Qiu, X. Xia, H. Zhou, T. M. Rana, and Z. Xu Therapeutic Gene Silencing Delivered by a Chemically Modified Small Interfering RNA against Mutant SOD1 Slows Amyotrophic Lateral Sclerosis Progression J. Biol. Chem., June 6, 2008; 283(23): 15845 - 15852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cao, S. V. Antonyuk, S. V. Seetharaman, L. J. Whitson, A. B. Taylor, S. P. Holloway, R. W. Strange, P. A. Doucette, J. S. Valentine, A. Tiwari, et al. Structures of the G85R Variant of SOD1 in Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., June 6, 2008; 283(23): 16169 - 16177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Karch and D. R. Borchelt A Limited Role for Disulfide Cross-linking in the Aggregation of Mutant SOD1 Linked to Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., May 16, 2008; 283(20): 13528 - 13537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jaarsma, E. Teuling, E. D. Haasdijk, C. I. De Zeeuw, and C. C. Hoogenraad Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice J. Neurosci., February 27, 2008; 28(9): 2075 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cozzolino, I. Amori, M. G. Pesaresi, A. Ferri, M. Nencini, and M. T. Carri Cysteine 111 Affects Aggregation and Cytotoxicity of Mutant Cu,Zn-superoxide Dismutase Associated with Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., January 11, 2008; 283(2): 866 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Niwa, S.-i. Yamada, S. Ishigaki, J. Sone, M. Takahashi, M. Katsuno, F. Tanaka, M. Doyu, and G. Sobue Disulfide Bond Mediates Aggregation, Toxicity, and Ubiquitylation of Familial Amyotrophic Lateral Sclerosis-linked Mutant SOD1 J. Biol. Chem., September 21, 2007; 282(38): 28087 - 28095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zetterstrom, H. G. Stewart, D. Bergemalm, P. A. Jonsson, K. S. Graffmo, P. M. Andersen, T. Brannstrom, M. Oliveberg, and S. L. Marklund Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models PNAS, August 28, 2007; 104(35): 14157 - 14162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sandelin, A. Nordlund, P. M. Andersen, S. S. L. Marklund, and M. Oliveberg Amyotrophic Lateral Sclerosis-associated Copper/Zinc Superoxide Dismutase Mutations Preferentially Reduce the Repulsive Charge of the Proteins J. Biol. Chem., July 20, 2007; 282(29): 21230 - 21236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Banci, I. Bertini, A. Durazo, S. Girotto, E. B. Gralla, M. Martinelli, J. S. Valentine, M. Vieru, and J. P. Whitelegge Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS PNAS, July 3, 2007; 104(27): 11263 - 11267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Taylor, B. F. Gibbs, E. Kabashi, S. Minotti, H. D. Durham, and J. N. Agar Tryptophan 32 Potentiates Aggregation and Cytotoxicity of a Copper/Zinc Superoxide Dismutase Mutant Associated with Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., June 1, 2007; 282(22): 16329 - 16335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Urushitani, S. A. Ezzi, and J.-P. Julien Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis PNAS, February 13, 2007; 104(7): 2495 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Carroll, C. E. Outten, J. B. Proescher, L. Rosenfeld, W. H. Watson, L. J. Whitson, P. J. Hart, L. T. Jensen, and V. C. Culotta The Effects of Glutaredoxin and Copper Activation Pathways on the Disulfide and Stability of Cu,Zn Superoxide Dismutase J. Biol. Chem., September 29, 2006; 281(39): 28648 - 28656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ferri, M. Cozzolino, C. Crosio, M. Nencini, A. Casciati, E. B. Gralla, G. Rotilio, J. S. Valentine, and M. T. Carri Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials PNAS, September 12, 2006; 103(37): 13860 - 13865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-X. Deng, Y. Shi, Y. Furukawa, H. Zhai, R. Fu, E. Liu, G. H. Gorrie, M. S. Khan, W.-Y. Hung, E. H. Bigio, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria PNAS, May 2, 2006; 103(18): 7142 - 7147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Furukawa, R. Fu, H.-X. Deng, T. Siddique, and T. V. O'Halloran From the Cover: Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice PNAS, May 2, 2006; 103(18): 7148 - 7153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bergemalm, P. A. Jonsson, K. S. Graffmo, P. M. Andersen, T. Brannstrom, A. Rehnmark, and S. L. Marklund Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J. Neurosci., April 19, 2006; 26(16): 4147 - 4154. [Abstract] [Full Text] [PDF]
|
|